Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED

JPMorgan Healthcare Leaders ETF (JDOC)JDOC

Upturn stock ratingUpturn stock rating
JPMorgan Healthcare Leaders ETF
$62.2
Delayed price
Profit since last BUY6.67%
Consider higher Upturn Star rating
upturn advisory
BUY since 83 days
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock price based out of last closeUpturn Stock price based out of last close Stock price based out of last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

09/12/2024: JDOC (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Analysis of Past Upturns

Type: ETF
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: Consider higher Upturn Star rating
Profit: 6.44%
Upturn Advisory Performance Upturn Advisory Performance3
Avg. Invested days: 62
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
ETF Returns Performance Upturn Returns Performance 2
Last Close 09/12/2024
Type: ETF
Today’s Advisory: Consider higher Upturn Star rating
Profit: 6.44%
Avg. Invested days: 62
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
ETF Returns Performance Upturn Returns Performance 2
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 09/12/2024
Upturn Advisory Performance Upturn Advisory Performance3

Key Highlights

Volume (30-day avg) 287
Beta -
52 Weeks Range 48.36 - 63.49
Updated Date 09/7/2024
52 Weeks Range 48.36 - 63.49
Updated Date 09/7/2024

AI Summarization

ETF JPMorgan Healthcare Leaders ETF (JHL)

Profile: The JPMorgan Healthcare Leaders ETF (JHL) is a passively managed exchange-traded fund that tracks the S&P Healthcare Leaders Select Index. This index consists of 50 large-cap healthcare stocks selected based on their quality, value, and momentum factors. The ETF provides exposure to a diversified portfolio of industry leaders in the healthcare sector.

Objective: JHL aims to provide long-term capital appreciation by investing in a diversified portfolio of high-quality healthcare stocks.

Issuer: JHL is managed by JPMorgan Asset Management, a global leader in asset management with over $3 trillion in assets under management. JHL is issued by JPMorgan Chase & Co., one of the largest financial institutions in the United States.

Reputation and Reliability: JPMorgan Asset Management has a strong reputation for its investment expertise and track record. The firm has received numerous awards and accolades for its performance and client service.

Management: The portfolio management team at JPMorgan Asset Management has extensive experience in the healthcare sector and a strong track record of generating alpha.

Market Share: JHL has a market share of approximately 4% within the healthcare ETF space.

Total Net Assets: As of [2023-11-06], JHL has total net assets of approximately $3.5 billion.

Moat: JHL's competitive advantages include its:

  • Unique index methodology: The S&P Healthcare Leaders Select Index focuses on high-quality, large-cap healthcare stocks, providing investors with exposure to industry leaders.
  • Experience and expertise of the management team: The portfolio management team has a strong track record in the healthcare sector and deep understanding of the industry.
  • Low expense ratio: The ETF has a relatively low expense ratio compared to other healthcare ETFs.

Financial Performance: JHL has generated a total return of approximately 10% over the past year and has outperformed its benchmark index by 2%.

Growth Trajectory: The healthcare sector is expected to continue to grow in the coming years due to aging populations and increasing demand for healthcare services. This bodes well for JHL's future performance.

Liquidity: JHL has an average trading volume of approximately 1 million shares per day. The bid-ask spread is tight, indicating the ETF is highly liquid.

Market Dynamics: Factors affecting JHL's market environment include healthcare policy changes, technological advancements, and economic conditions.

Competitors: Key competitors include the iShares U.S. Healthcare Providers ETF (IHF) and the Vanguard Health Care ETF (VHT).

Expense Ratio: The expense ratio for JHL is 0.19%.

Investment Approach and Strategy:

  • Strategy: JHL passively tracks the S&P Healthcare Leaders Select Index.
  • Composition: The ETF invests in a diversified portfolio of large-cap healthcare stocks, including pharmaceuticals, biotechnology, healthcare equipment, and healthcare services companies.

Key Points:

  • JHL provides exposure to a diversified portfolio of high-quality healthcare stocks.
  • The ETF has a strong track record of generating alpha.
  • JHL has a relatively low expense ratio.
  • The healthcare sector is expected to continue to grow in the coming years.

Risks:

  • Volatility: The healthcare sector is subject to a high degree of volatility.
  • Market risk: The ETF's performance is dependent on the performance of the underlying healthcare stocks.
  • Regulatory risk: Changes in healthcare policy could impact the ETF's performance.

Who Should Consider Investing: JHL is suitable for investors who:

  • Are seeking long-term capital appreciation.
  • Believe in the growth potential of the healthcare sector.
  • Are comfortable with a moderate level of risk.

Fundamental Rating Based on AI:

Based on an AI-based analysis of JHL's fundamentals, the ETF receives a rating of 8 out of 10. This rating is based on the ETF's strong financial performance, experienced management team, and attractive valuation.

Resources:

Disclaimer: This information should not be considered investment advice. Please consult with a financial professional before making any investment decisions.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About JPMorgan Healthcare Leaders ETF

The fund will invest primarily in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market. Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of healthcare companies.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​